Learn / IMVT
NASDAQ: IMVT
Immunovant (IMVT) stock, explained like you're 5
Immunovant trades on the Nasdaq under the ticker IMVT. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 6.3 billion dollars.
- Ticker
- IMVT
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Mid cap, about 6.3 billion dollars
Is Immunovant a small, medium or large cap company?
No. Immunovant is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 6.3 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Immunovant makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves IMVT stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- IMVT Nov 2026 31.000 call (IMVT261120C00031000) Stock Price, News, Quote & History (Yahoo! Finance Canada)
- Immunovant Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Immunovant (IMVT) (PR Newswire)
- IMVT, ROIV Stocks Slide As Argenx Sjögren’s Trial Failure Hits Drug Class (Stocktwits)
- Immunovant Shares Results from Proof of Concept Study of Imeroprubart in Cutaneous Lupus (Lupus Foundation of America)
- IMVT Nov 2026 30.000 put (IMVT261120P00030000) Stock Price, News, Quote & History (Yahoo! Finance Canada)
Follow IMVT in your daily brief
Each trading day at 5 PM ET we post what happened to Immunovant and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow IMVT
Questions about Immunovant stock
What does Immunovant do?
Immunovant trades on the Nasdaq under the ticker IMVT. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 6.3 billion dollars.
What is the ticker symbol for Immunovant?
Immunovant trades under the ticker IMVT on the Nasdaq.
What is Immunovant's market cap?
Immunovant is a mid cap stock with a market cap of about 6.3 billion dollars.
How does Immunovant make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves IMVT stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow IMVT stock every day?
Add IMVT to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.